Home > News > NASDAQ Approves Arrowhead Research Corporation for Trading
August 30th, 2004
NASDAQ Approves Arrowhead Research Corporation for Trading
Abstract:
Arrowhead Research Corporation (OTCBB: ARWR), an emerging company in the field of nanotechnology, announced today that NASDAQ has approved the Company's common stock and common stock purchase warrants (ARWRW) for listing on the NASDAQ SmallCap Market(TM), subject to certain conditions. The Company expects its stock to begin trading on the SmallCap Market within the next ten trading days.
Source:
Businesswire
Related News Press |
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||